Clinical trial
A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to Using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations
NCT04107779 is registered in ClinicalTrials.gov with Juul Labs, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Open Label, Parallel Group Study in Adult Smokers to Evaluate Changes in Biomarkers of Cigarette Smoke Exposure After Switching Either Exclusively or Partly to Using JUUL Electronic Nicotine Delivery Systems With Two Different Nicotine Concentrations
- Lead sponsor
- Juul Labs, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 17, 2019
- Completion date
- June 24, 2020
- Enrollment
- 279 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
cigarette use, electronic, electronic cigarette use, tobacco smoking, tobacco use